EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Improved Therapeutic Efficacy of Doxorubicin Chemotherapy With Cannabidiol in 4T1 Mice Breast Cancer Model

Koorosh Tabatabaei, Sara Moazzezi, Mohammadreza Emamgholizadeh, Haleh Vaez iD, Behzad Baradaran, Behrooz Shokouhi

Cancer Medicine · 2024

DOI: 10.1002/cam4.70395 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Koorosh Tabatabaei und 5 weiteren Autor:innen. Beteiligte Einrichtung: Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran. Hauptthemen laut MEDLINE: Doxorubicin, Cannabidiol, Matrix Metalloproteinase 2, Nitric Oxide Synthase Type II. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran, Student Research Committee, Tabriz University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

High dose chemotherapy is one of the therapeutic strategies for breast cancer and doxorubicin (DOX) as a chemotherapy agent is widely used. DOX indication is limited due to its dose‐depended cardiotoxicity. Recently, cannabidiol (CBD) shows antitumoral and cardioprotective effects, so we hypothesized that CBD administration with high‐dose DOX chemotherapy can improve anticancer activity and reduce cardiotoxic side effects.

Method

Mice breast cancer model established by injecting 4T1 cell lines. One group was not injected by 4T1 cells as a not cancerous group and received normal saline (NS, 0.1 mL). In cancerous groups, first group was considered as cancerous control and received NS (0.1 mL); the second group received CBD (5 mg/kg, IP) on Days 1,7, and 14; in the third group DOX (5 mg/kg, IV) as CBD schedule was administrated; the fourth group treated with CBD 1 day before DOX injection as pretreatment, and the last group was treated with CBD and DOX at same time with previous doses and schedules. On Day 21, all mice were sacrificed, heart and lungs tissues were obtained and histological sections were isolated. SOD2, iNOS, MMP2, MMP9 were evaluated through western blot and TUNEL test preformed for breast tumor.

Results

Tumor size and weight significantly decreased in DOX, pretreatment CBD + DOX and CBD + DOX groups. Administration of CBD with DOX could not prevent weight loss. TUNEL test demonstrated the highest tumor cell apoptosis in pretreatment CBD + DOX and CBD + DOX. In lungs belonged to CBD + DOX, there was not any sign of metastasis. Cardiac histopathological examination of pretreatment CBD + DOX and CBD + DOX did not show any sign of congestion or inflammation. In CBD + DOX SOD2 increased, also iNOS, MMP2, and MMP9 decreased compared to DOX.

Conclusions

This study demonstrated that simultaneous administration of CBD and DOX can increase antitumoral effect and reduce DOX cardiotoxicity. Nevertheless, CBD can induce cardiotoxicity as administrated alone.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinCannabidiolMatrix Metalloproteinase 2Nitric Oxide Synthase Type IIMatrix Metalloproteinase 9Superoxide DismutaseAnimalsFemaleMiceCell Line, TumorDisease Models, AnimalBreast NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsCardiotoxicityApoptosisMice, Inbred BALB CSuperoxide Dismutase 2

Stichwörter der Autor:innen

breast cancercannabidiolcardiotoxicitydoxorubicinlung metastasis

Substanzen

DoxorubicinCannabidiolMatrix Metalloproteinase 2Nitric Oxide Synthase Type IIMatrix Metalloproteinase 9Superoxide DismutaseSuperoxide Dismutase 2Mmp2 protein, mouseNos2 protein, mouseMmp9 protein, mouse

Autor:innen und Institutionen

  • Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Faculty of Veterinary Medicine, Tabriz Islamic Azad University, Tabriz, Iran.
  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Department of Pathology, Tabriz University of Medical Sciences, Tabriz, Iran.

ORCID-Profile: Haleh Vaez

Förderung

  • Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran
  • Student Research Committee, Tabriz University of Medical Sciences

Zitieren

APA

Tabatabaei, K., Moazzezi, S., Emamgholizadeh, M., Vaez, H., Baradaran, B., & Shokouhi, B. (2024). Improved Therapeutic Efficacy of Doxorubicin Chemotherapy With Cannabidiol in 4T1 Mice Breast Cancer Model. Cancer Medicine. https://doi.org/10.1002/cam4.70395

Vancouver

Tabatabaei K, Moazzezi S, Emamgholizadeh M, Vaez H, Baradaran B, Shokouhi B. Improved Therapeutic Efficacy of Doxorubicin Chemotherapy With Cannabidiol in 4T1 Mice Breast Cancer Model. Cancer Medicine. 2024. doi:10.1002/cam4.70395

BibTeX
@article{Tabatabaei2024,
  author = {Tabatabaei, Koorosh and Moazzezi, Sara and Emamgholizadeh, Mohammadreza and Vaez, Haleh and Baradaran, Behzad and Shokouhi, Behrooz},
  title = {Improved Therapeutic Efficacy of Doxorubicin Chemotherapy With Cannabidiol in 4T1 Mice Breast Cancer Model},
  journal = {Cancer Medicine},
  year = {2024},
  doi = {10.1002/cam4.70395}
}
Kostenlos starten →